Medications ›cefprozil anhydrous

cefprozil anhydrous

RxCUI 1546020 precise ingredient

Contraindicated with · 3

Diagnoses1

Condition families2

Indicated for · 34

Diagnoses8

Pharyngitis Otitis Media Sinusitis Otitis Bronchitis Skin Diseases, Bacterial Lung Diseases, Obstructive Skin Diseases, Infectious

Condition families26

Moraxellaceae Infections Pharyngeal Diseases Paranasal Sinus Diseases Ear Diseases Proteus Infections Haemophilus Infections Pasteurellaceae Infections Klebsiella Infections Stomatognathic Diseases Escherichia coli Infections Nose Diseases Enterobacteriaceae Infections Staphylococcal Infections Streptococcal Infections Otorhinolaryngologic Diseases Gram-Negative Bacterial Infections Bronchial Diseases Respiratory Tract Infections Gram-Positive Bacterial Infections Bacterial Infections Bacterial Infections and Mycoses Lung Diseases Skin Diseases Respiratory Tract Diseases Skin and Connective Tissue Diseases Infections

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.